Clinical Trial Update: Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

View source ↗

Summary

An observational study of patients receiving Dupixent (dupilumab) for atopic dermatitis, with study status currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Sanofi | Conditions: Dermatitis Atopic | Status: ACTIVE_NOT_RECRUITING